These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

372 related items for PubMed ID: 15529364

  • 1. Measurement of erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus.
    Manzi S, Navratil JS, Ruffing MJ, Liu CC, Danchenko N, Nilson SE, Krishnaswami S, King DE, Kao AH, Ahearn JM.
    Arthritis Rheum; 2004 Nov; 50(11):3596-604. PubMed ID: 15529364
    [Abstract] [Full Text] [Related]

  • 2. Platelet C4d is highly specific for systemic lupus erythematosus.
    Navratil JS, Manzi S, Kao AH, Krishnaswami S, Liu CC, Ruffing MJ, Shaw PS, Nilson AC, Dryden ER, Johnson JJ, Ahearn JM.
    Arthritis Rheum; 2006 Feb; 54(2):670-4. PubMed ID: 16447243
    [Abstract] [Full Text] [Related]

  • 3. Usefulness of erythrocyte-bound C4d as a biomarker to predict disease activity in patients with systemic lupus erythematosus.
    Yang DH, Chang DM, Lai JH, Lin FH, Chen CH.
    Rheumatology (Oxford); 2009 Sep; 48(9):1083-7. PubMed ID: 19553377
    [Abstract] [Full Text] [Related]

  • 4. Erythrocyte C4d and complement receptor 1 in systemic lupus erythematosus.
    Singh V, Mahoney JA, Petri M.
    J Rheumatol; 2008 Oct; 35(10):1989-93. PubMed ID: 18709693
    [Abstract] [Full Text] [Related]

  • 5. Reticulocytes bearing C4d as biomarkers of disease activity for systemic lupus erythematosus.
    Liu CC, Manzi S, Kao AH, Navratil JS, Ruffing MJ, Ahearn JM.
    Arthritis Rheum; 2005 Oct; 52(10):3087-99. PubMed ID: 16200588
    [Abstract] [Full Text] [Related]

  • 6. Measurement of cell-bound complement activation products enhances diagnostic performance in systemic lupus erythematosus.
    Kalunian KC, Chatham WW, Massarotti EM, Reyes-Thomas J, Harris C, Furie RA, Chitkara P, Putterman C, Gross RL, Somers EC, Kirou KA, Ramsey-Goldman R, Hsieh C, Buyon JP, Dervieux T, Weinstein A.
    Arthritis Rheum; 2012 Dec; 64(12):4040-7. PubMed ID: 22932861
    [Abstract] [Full Text] [Related]

  • 7. Measurement of human erythrocyte C4d to erythrocyte complement receptor 1 ratio in cardiac transplant recipients with acute symptomatic allograft failure.
    Lee KC, Chang CY, Chuang YC, Sue SH, Chu TW, Chen RJ, Chen SH, Wei J, Chen CH.
    Transplant Proc; 2008 Oct; 40(8):2638-42. PubMed ID: 18929826
    [Abstract] [Full Text] [Related]

  • 8. Disease-associated loss of erythrocyte complement receptors (CR1, C3b receptors) in patients with systemic lupus erythematosus and other diseases involving autoantibodies and/or complement activation.
    Ross GD, Yount WJ, Walport MJ, Winfield JB, Parker CJ, Fuller CR, Taylor RP, Myones BL, Lachmann PJ.
    J Immunol; 1985 Sep; 135(3):2005-14. PubMed ID: 4020137
    [Abstract] [Full Text] [Related]

  • 9. CR1 on erythrocytes of Brazilian systemic lupus erythematosus patients: the influence of disease activity on expression and ability of this receptor to bind immune complexes opsonized with complement from normal human serum.
    Marzocchi-Machado CM, Alves CM, Azzolini AE, Polizello AC, Carvalho IF, Lucisano-Valim YM.
    J Autoimmun; 2005 Dec; 25(4):289-97. PubMed ID: 16289666
    [Abstract] [Full Text] [Related]

  • 10. Erythrocyte complement receptor type 1 in patients with systemic lupus erythematosus.
    Yen JH, Liu HW, Lin SF, Chen JR, Chen TP.
    J Rheumatol; 1989 Oct; 16(10):1320-5. PubMed ID: 2810256
    [Abstract] [Full Text] [Related]

  • 11. Analysis of Erythrocyte C4d to Complement Receptor 1 Ratio: Use in Distinguishing between Infection and Flare-Up in Febrile Patients with Systemic Lupus Erythematosus.
    Chen CH, Tai SB, Chen HC, Yang DH, Peng MY, Lin YF.
    Biomed Res Int; 2015 Oct; 2015():939783. PubMed ID: 26273660
    [Abstract] [Full Text] [Related]

  • 12. Low number of complement C3b/C4b receptors (CR1) on erythrocytes from patients with essential mixed cryoglobulinemia, systemic lupus erythematosus and rheumatoid arthritis: relationship with disease activity, anticardiolipin antibodies, complement activation and therapy.
    Corvetta A, Pomponio G, Bencivenga R, Luchetti MM, Spycher M, Spaeth PJ, Danieli G.
    J Rheumatol; 1991 Jul; 18(7):1021-5. PubMed ID: 1833542
    [Abstract] [Full Text] [Related]

  • 13. Expression of Fcgamma and complement receptors on peripheral blood monocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Hepburn AL, Mason JC, Davies KA.
    Rheumatology (Oxford); 2004 May; 43(5):547-54. PubMed ID: 14747618
    [Abstract] [Full Text] [Related]

  • 14. [Flow cytometric measurement of C3b receptors (CR1) on human erythrocytes. II. E-CR1 levels in patients with various diseases and their correlation with B-CR1].
    Itoh Y, Fukunaga Y, Yamamoto M.
    Arerugi; 1989 Nov; 38(11):1276-87. PubMed ID: 2534036
    [Abstract] [Full Text] [Related]

  • 15. Reduced complement receptor 1 (CR1, CD35) transcription in systemic lupus erythematosus.
    Arora V, Verma J, Dutta R, Marwah V, Kumar A, Das N.
    Mol Immunol; 2004 Jun; 41(4):449-56. PubMed ID: 15163541
    [Abstract] [Full Text] [Related]

  • 16. Family studies of erythrocyte complement receptor type 1 levels: reduced levels in patients with SLE are acquired, not inherited.
    Walport MJ, Ross GD, Mackworth-Young C, Watson JV, Hogg N, Lachmann PJ.
    Clin Exp Immunol; 1985 Mar; 59(3):547-54. PubMed ID: 3987091
    [Abstract] [Full Text] [Related]

  • 17. Diminished ability of erythrocytes from patients with systemic lupus erythematosus to limit opsonized immune complex deposition on leukocytes and activation of granulocytes.
    Nielsen CH, Rasmussen JM, Voss A, Junker P, Leslie RG.
    Arthritis Rheum; 1998 Apr; 41(4):613-22. PubMed ID: 9550470
    [Abstract] [Full Text] [Related]

  • 18. Increased C1q, C4 and C3 deposition on platelets in patients with systemic lupus erythematosus--a possible link to venous thrombosis?
    Lood C, Eriksson S, Gullstrand B, Jönsen A, Sturfelt G, Truedsson L, Bengtsson AA.
    Lupus; 2012 Nov; 21(13):1423-32. PubMed ID: 22878256
    [Abstract] [Full Text] [Related]

  • 19. [Erythrocyte CR1 receptor reactivity in patients with systemic lupus erythematosus].
    Said PB, Sarano J, Manni JA, Casellas AM.
    Medicina (B Aires); 1990 Nov; 50(1):21-4. PubMed ID: 2149869
    [Abstract] [Full Text] [Related]

  • 20. Elevated levels of soluble fractalkine in active systemic lupus erythematosus: potential involvement in neuropsychiatric manifestations.
    Yajima N, Kasama T, Isozaki T, Odai T, Matsunawa M, Negishi M, Ide H, Kameoka Y, Hirohata S, Adachi M.
    Arthritis Rheum; 2005 Jun; 52(6):1670-5. PubMed ID: 15934075
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.